- European Perspectives
- About us
STO Fellows' Forum (STOFF)
The Society for Translational Oncology Fellows' Forum (STOFF) is a 3-day intensive forum that brings together fellows and junior faculty within 5 years of training completion from the leading medical, surgical, and radiation oncology subspecialty fellowships to educate rising stars in translational cancer research.
The number of scholars selected for participation in this workshop will be limited to a total of 25 in order to have ample opportunity for one-on-one interface with the prestigious faculty as well as peer-to-peer networking.
To help meet the educational and health needs of today's society and future generations, STO is committed to speeding the discovery and translation of important new treatments in the field of cancer medicine to the practice of global oncology by:
STOFF's impact is global as its alumni will conduct research that will have worldwide influence.
Session Summaries Coming Soon!
October 22-25, 2015
Cancer Drug Development: Views from Industry and Academia Gregory Curt, MD and Keith T. Flaherty, MD Summary (PDF)
The Role of Targeted Therapies and Drug Resistance Bruce A. Chabner, MD Summary (PDF)
Issues in the Design of Translational Research Trials Susan Hilsenbeck, PhD Summary (PDF)
The Cost and Value of Cancer Medicine Gregory Curt, MD Summary (PDF)
Project Data Sphere® Martin J. Murphy, DMedSc, PhD, FASCO, Gregory Curt, MD and Elliot Inman, PhD Summary (PDF)
The Cancer Genome Atlas (TCGA) William Kim, MD Summary (PDF)
Guidelines for Good Scientific Practice Mark W. Duncan, PhD Summary (PDF)
New Advances in Genomics and Arrays Luis Diaz, MD Summary (PDF)
Pharmacogenomics Peter H. O'Donnell, MD Summary (PDF)
How to Write a Grant Keith T. Flaherty, MD Summary (PDF)
Principal Investigator (PI) Responsibilities and Conflict of Interest Stacey Berg, MD Summary (PDF)
Oncology Drug Development: A Regulatory Perspective Tatiana Prowell, MD Summary (PDF)
Receptor-Associated Kinase Inhibitor Jeffrey Engelman, MD, PhD Summary (PDF)
Intracellular Resistance Pathways Jeffrey Engelman, MD, PhD Summary (PDF)
Cellular Therapy: Cytokines, TILs, CAR-T's and Vaccines Ryan Sullivan, MD Summary (PDF)
Immune Checkpoint Inhibition in Advanced CancerGordon Freeman, PhD Summary (PDF)